SCHEMBL8525225

SCHEMBL8525225

O=C(C1CCc2nc[nH]c2C1)N1CC(c2cccc(O)c2)c2ccccc21

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 2/20 0.42
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
ADRA2C P18825 1/20 0.42
SLC6A4 P31645 1/20 0.42
OPRK1 P41145 1/20 0.42
HTR2B P41595 1/20 0.42
KCNH2 Q12809 1/20 0.42
HTR3E A5X5Y0 1/20 0.42
HTR3B O95264 1/20 0.42
HTR3D Q70Z44 1/20 0.42
HTR3C Q8WXA8 1/20 0.42
ADRA1A P35348 6/20 0.41
ADRA1D P25100 1/20 0.37
IDH1 O75874 5/20 0.36
KIF11 P52732 4/20 0.36
ESR2 Q92731 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8540902 0.99 HTR3A (0.41) HTR3AADRA2AADRA2BADRA2CSLC6A4
SCHEMBL8525220 0.93 IDH1 (0.36) HTR3AADRA2AADRA2BADRA2CSLC6A4
Hydrochloric Acid SCHEMBL8540899 0.92 IDH1 (0.35) HTR3AADRA2AADRA2BADRA2CSLC6A4
SCHEMBL8479745 0.91 ADRA1A (0.48) HTR3AADRA2AADRA2BADRA2CSLC6A4
SCHEMBL8542709 0.90 HTR3A (0.41) HTR3AADRA2AADRA2BADRA2CSLC6A4
SCHEMBL8538946 0.90 HTR3A (0.43) HTR3AADRA2AADRA2BADRA2CSLC6A4
Hydrochloric Acid SCHEMBL8538099 0.90 ADRA1A (0.47) HTR3AADRA2AADRA2BADRA2CSLC6A4
Hydrochloric Acid SCHEMBL8539599 0.89 HTR3A (0.43) HTR3AADRA2AADRA2BADRA2CSLC6A4
SCHEMBL8538551 0.88 ADRA1A (0.44) HTR3AADRA2AADRA2BADRA2CSLC6A4
SCHEMBL8540950 0.88 ADRA1A (0.55) HTR3AADRA2AADRA2BADRA2CSLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0721949-B1 INDOLINE COMPOUND AND 5-HT 3? RECEPTOR ANTAGONIST CONTAINING THE SAME AS ACTIVE INGREDIENT TOKYO TANABE CO (JP) 1998-01-07 EP claimed
US-5677326-A GASTROINTESTINAL DISORDERS TOKYO TANABE COMPANY LIMITED (JP) 1997-10-14 US claimed
EP-0721949-A1 INDOLINE COMPOUND AND 5-HT 3? RECEPTOR ANTAGONIST CONTAINING THE SAME AS ACTIVE INGREDIENT TOKYO TANABE COMPANY LIMITED (JP) 1996-07-17 EP claimed
US-5936098-A Process for producing indoline compounds and intermediates for the production of the same TOKYO TANABE COMPANY LIMITED (JP) 1999-08-10 US disclosed
EP-0721949-B1 INDOLINE COMPOUND AND 5-HT 3? RECEPTOR ANTAGONIST CONTAINING THE SAME AS ACTIVE INGREDIENT TOKYO TANABE CO (JP) 1998-01-07 EP disclosed
EP-0810214-A1 PROCESS FOR PRODUCING INDOLINE COMPOUNDS AND INTERMEDIATES FOR THE PRODUCTION OF THE SAME TOKYO TANABE COMPANY LIMITED (JP) 1997-12-03 EP disclosed
US-5677326-A GASTROINTESTINAL DISORDERS TOKYO TANABE COMPANY LIMITED (JP) 1997-10-14 US disclosed
EP-0721949-A1 INDOLINE COMPOUND AND 5-HT 3? RECEPTOR ANTAGONIST CONTAINING THE SAME AS ACTIVE INGREDIENT TOKYO TANABE COMPANY LIMITED (JP) 1996-07-17 EP disclosed